Source: Eur Respir J 2014; 43: 966-969



Rating:

Share or cite this content

Citations should be made in the following way:
Cottin Vincent. Treatment of lymphangioleiomyomatosis: building evidence in orphan diseases. Eur Respir J 2014; 43: 966-969

Member's Comments

No comment yet.

Related content which might interest you: Rare pulmonary disease and orphan drugs: a path to the future Source: Eur Respir Rev, 28 (153) 190115; 10.1183/16000617.0115-2019 Year: 2019 Toward better management of rare and orphan pulmonary diseases Source: Eur Respir J 2016; 47:1334-1335 Year: 2016 Rare and orphan lung diseases Source: ISSN=ISSN 1810-6838, ISBN=, page=146 Year: 2005 Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to? Source: Eur Respir Rev 2015; 24: 375-377 Year: 2015 Caring for the orphan's orphan: treatment of patients with portopulmonary hypertension Source: Eur Respir J 2007; 30: 1038-1040 Year: 2007 Global effort against rare and orphan diseases Source: Eur Respir Rev 2012 21:171-172 Year: 2012 Global effort against rare and orphan diseases Source: Annual Congress 2013 –European Respiratory Review: what's hot in pulmonary medicine Year: 2013 Lymphangioma in patients with pulmonary lymphangioleiomyomatosis – Results of sirolimus treatment Source: International Congress 2016 – Orphan diseases I Year: 2016 Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis? Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Lung involvement distinct from pulmonary hypertension: a new feature of POEMS syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 371s Year: 2002 Rare lung diseases in children: challenges for diagnosis and treatment Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021 Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early Spanish experience with the European Named patient program (NPP) Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 Cleaning agents and chronic lung disease: does the evidence support a link with COPD? Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health? Year: 2018 Clinical management of the idiopathic interstitial pneumonias: an example of an integrated approach to interstitial lung diseases Source: Annual Congress 2006 - PG8 - Interstitial lung diseases: idiopathic interstitial pneumonias Year: 2006